We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > PrEP

News List

USPSTF Issues Recommendations on HIV Screening, Prevention drugs
June 12, 2019
USPSTF Issues Recommendations on HIV Screening, Prevention.
Generic Version of Truvada Available in U.S. by Sept. 2020 drugs
May 10, 2019
Generic Version of Truvada Available in U.S. by Sept. 2020.
UK is among the first to meet UN targets for HIV treatment and prevention, Public Health England says pharmafile
November 30, 2018
The UK is among the first countries in the world to meet the HIV treatment targets set out by the UNAIDS 90-90-90 programme, according to a new report form Public Health England.
Anti-HIV drug PrEP proves safety in gay and bisexual adolescents pharmafile
September 07, 2017
A new study has found that pre-exposure prophylaxis (PrEP) drugs such as Gilead's Truvada (emtricitabine/tenofovir disoproxil fumarate)
NHS England launches trial to assess PrEP pharmatimes
August 08, 2017
NHS England has kicked off what it claims to be the world’s largest single trial assessing the full impact of a scheme that gives patients at high risk of contracting HIV drugs to prevent infection.

Previous page 1 2 Next page